Augustine, FL, United States of America

Dale M Edgar

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Alairion, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dale M Edgar. Retrieved from https://idiyas.com/inventor/dale-m-edgar-070ogzcc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dale M Edgar: Innovator in Pharmaceutical Compounds

Introduction

Dale M Edgar is a notable inventor based in Augustine, FL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the treatment of sleep disorders.

Latest Patents

Dale M Edgar holds a patent for "Piperazine substituted azapine derivatives and uses thereof." This patent relates to compounds of Formula (I) and (II), including their prodrugs, pharmaceutically acceptable salts, and pharmaceutical compositions. The compounds disclosed are useful for modulating H1 and 5-HT receptors, aimed at treating sleep disorders such as sleep fragmentation, disturbed sleep/arousals, and arousal threshold.

Career Highlights

Dale is currently associated with Alairion, Inc., where she continues to innovate in the pharmaceutical sector. Her work focuses on creating effective treatments that improve the quality of sleep for individuals suffering from various sleep-related issues.

Collaborations

Dale collaborates with Mark E Duggan, contributing to the advancement of their research and development efforts in the pharmaceutical industry.

Conclusion

Dale M Edgar's work exemplifies the impact of innovative thinking in the pharmaceutical field, particularly in addressing sleep disorders through her patented compounds. Her contributions are vital for the ongoing development of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…